These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24395808)

  • 1. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis.
    Kim Y; Lobatto ME; Kawahara T; Lee Chung B; Mieszawska AJ; Sanchez-Gaytan BL; Fay F; Senders ML; Calcagno C; Becraft J; Tun Saung M; Gordon RE; Stroes ES; Ma M; Farokhzad OC; Fayad ZA; Mulder WJ; Langer R
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1078-83. PubMed ID: 24395808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin.
    Setyawati MI; Tay CY; Bay BH; Leong DT
    ACS Nano; 2017 May; 11(5):5020-5030. PubMed ID: 28422481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Intravenous Nanoparticle Delivery: Role of Flow and Endothelial Glycocalyx Integrity.
    Cheng MJ; Mitra R; Okorafor CC; Nersesyan AA; Harding IC; Bal NN; Kumar R; Jo H; Sridhar S; Ebong EE
    Ann Biomed Eng; 2020 Jul; 48(7):1941-1954. PubMed ID: 32072383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging.
    Stein-Merlob AF; Hara T; McCarthy JR; Mauskapf A; Hamilton JA; Ntziachristos V; Libby P; Jaffer FA
    Circ Cardiovasc Imaging; 2017 May; 10(5):. PubMed ID: 28487316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction and permeability via the mitogen-activated protein kinase pathway in a rabbit model of atherosclerosis.
    Ding J; Li Z; Li L; Ding Y; Wang D; Meng S; Zhou Q; Gui S; Wei W; Zhu H; Wang Y
    Biomed Pharmacother; 2020 Aug; 128():110258. PubMed ID: 32516749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.
    Zhang H; Zhang L; Myerson J; Bibee K; Scott M; Allen J; Sicard G; Lanza G; Wickline S
    PLoS One; 2011; 6(10):e26385. PubMed ID: 22028868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time assessment of nanoparticle-mediated antigen delivery and cell response.
    Cunha-Matos CA; Millington OR; Wark AW; Zagnoni M
    Lab Chip; 2016 Aug; 16(17):3374-81. PubMed ID: 27455884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.
    Lobatto ME; Calcagno C; Millon A; Senders ML; Fay F; Robson PM; Ramachandran S; Binderup T; Paridaans MP; Sensarn S; Rogalla S; Gordon RE; Cardoso L; Storm G; Metselaar JM; Contag CH; Stroes ES; Fayad ZA; Mulder WJ
    ACS Nano; 2015 Feb; 9(2):1837-47. PubMed ID: 25619964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.
    Wei X; Ying M; Dehaini D; Su Y; Kroll AV; Zhou J; Gao W; Fang RH; Chien S; Zhang L
    ACS Nano; 2018 Jan; 12(1):109-116. PubMed ID: 29216423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.
    Calcagno C; Lairez O; Hawkins J; Kerr SW; Dugas MS; Simpson T; Epskamp J; Robson PM; Eldib M; Bander I; K-Raman P; Ramachandran S; Pruzan A; Kaufman A; Mani V; Ehlgen A; Niessen HG; Broadwater J; Fayad ZA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):291-301. PubMed ID: 29413439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the uptake of methacrylate-based nanoparticles in static and dynamic in vitro systems as well as in vivo.
    Rinkenauer AC; Press AT; Raasch M; Pietsch C; Schweizer S; Schwörer S; Rudolph KL; Mosig A; Bauer M; Traeger A; Schubert US
    J Control Release; 2015 Oct; 216():158-68. PubMed ID: 26277064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnological approach to delivering nutraceuticals as promising drug candidates for the treatment of atherosclerosis.
    Pillai SC; Borah A; Jacob EM; Kumar DS
    Drug Deliv; 2021 Dec; 28(1):550-568. PubMed ID: 33703990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.
    Cui J; Kessinger CW; McCarthy JR; Sosnovik DE; Libby P; Thadhani RI; Jaffer FA
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):189-96. PubMed ID: 25395614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin.
    Kanshana JS; Khanna V; Singh V; Jain M; Misra A; Kumar S; Farooqui M; Barthwal MK; Dikshit M
    J Cardiovasc Pharmacol; 2017 May; 69(5):314-325. PubMed ID: 28207427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study.
    Phinikaridou A; Hua N; Pham T; Hamilton JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):302-10. PubMed ID: 23357244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.
    Slevin M; Badimon L; Grau-Olivares M; Ramis M; Sendra J; Morrison M; Krupinski J
    Mol Biosyst; 2010 Mar; 6(3):444-50. PubMed ID: 20174673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles.
    Su T; Wang YB; Han D; Wang J; Qi S; Gao L; Shao YH; Qiao HY; Chen JW; Liang SH; Nie YZ; Li JY; Cao F
    Theranostics; 2017; 7(19):4791-4804. PubMed ID: 29187904
    [No Abstract]   [Full Text] [Related]  

  • 20. Imaging the Permeable Endothelium: Predicting Plaque Rupture in Atherosclerotic Rabbits.
    Calcagno C; Fayad ZA
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.